NYSE:CAH

Cardinal Health - CAH Stock Forecast, Price & News

$79.72

-0.45 (-0.56%)

(As of 12/1/2022 12:33 PM ET)

Add

Compare

Today's Range: $78.56
▼
$80.31
50-Day Range: $65.77
▼
$80.98
52-Week Range: $45.85
▼
$81.57

Volume: 62,589 shs
Average Volume: 3.05 million shs
Market Capitalization: $20.90 billion

P/E Ratio: 13.03
Dividend Yield: 2.52%
Price Target: $76.45

Cardinal Health MarketRank™ Forecast

Analyst Rating: Hold
2.27 Rating Score
Upside/Downside: 3.6% Downside
$76.45 Price Target
Short Interest: Healthy
3.28% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -2.65
Upright™ Environmental Score
News Sentiment: 0.44
Based on 4 Articles This Week
Insider Trading: Selling Shares
$1.55 M Sold Last Quarter
Proj. Earnings Growth: 13.64%
From $5.28 to $6.00 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.00 out of 5 stars

Medical Sector

14th out of 1,047 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 7 stocks

2.1

Analyst's Opinion

Consensus Rating
Cardinal Health has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 3 buy ratings, 8 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $76.45, Cardinal Health has a forecasted downside of 3.6% from its current price of $79.33.
Amount of Analyst Coverage
Cardinal Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
3.28% of the float of Cardinal Health has been sold short.
Short Interest Ratio / Days to Cover
Cardinal Health has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cardinal Health has recently decreased by 28.27%, indicating that investor sentiment is improving significantly.

4.2

Dividend Strength

Dividend Yield
Cardinal Health pays a meaningful dividend of 2.52%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Cardinal Health has been increasing its dividend for 36 years.
Dividend Coverage
The dividend payout ratio of Cardinal Health is 32.35%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 33.00% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

3.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Cardinal Health has received a 44.99% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wholesale of antisera and vaccines", "Wholesale of cancer medication", "Wholesale of rheumatoid medication", and "Wholesale of immunosupressive medication" products. See details.
Environmental Sustainability
The Environmental Impact score for Cardinal Health is -2.65.

2.5

News and Social Media Coverage

News Sentiment
Cardinal Health has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Cardinal Health this week, compared to 6 articles on an average week.
Search Interest
42 people have searched for CAH on MarketBeat in the last 30 days. This is an increase of 24% compared to the previous 30 days.
MarketBeat Follows
12 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cardinal Health insiders have sold 12,817.51% more of their company's stock than they have bought. Specifically, they have bought $11,961.00 in company stock and sold $1,545,063.00 in company stock.
Percentage Held by Insiders
Only 0.17% of the stock of Cardinal Health is held by insiders.
Percentage Held by Institutions
85.07% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Cardinal Health are expected to grow by 13.64% in the coming year, from $5.28 to $6.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cardinal Health is 12.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.90.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cardinal Health is 12.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 103.57.
Price to Earnings Growth Ratio
Cardinal Health has a PEG Ratio of 1.33. PEG Ratios above 1 indicate that a company could be overvalued.

See Top Rated MarketRank™ Stocks Here

About Cardinal Health (NYSE:CAH) Stock

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

CAH Stock News Headlines

November 2, 2022 | marketbeat.com

CVS, Walgreens announce opioid settlements totaling $10B

Two of the largest U

November 2, 2022 | marketbeat.com

Asian benchmarks mixed as markets await Fed rate moves

Asian shares are mixed while Chinese shares surged ahead of a decision by the U.S. Federal Reserve on an interest rate increase to curb inflation

November 23, 2022 | americanbankingnews.com

Cardinal Health (NYSE:CAH) Price Target Increased to $79.00 by Analysts at Credit Suisse Group

November 22, 2022 | nasdaq.com

Good Stocks To Invest In Now? 3 Dividend Aristocrats Stocks For Your List

November 22, 2022 | markets.businessinsider.com

6 Analysts Have This to Say About Cardinal Health

November 22, 2022 | finance.yahoo.com

5 Stocks To Be Thankful for in 2022

November 16, 2022 | msn.com

Elliott raises stake in Pinterest; adds Clarivate, Cardinal Health to portfolio

November 15, 2022 | finance.yahoo.com

Cardinal Health brings hospital-level care to the home with new supply chain solution

November 14, 2022 | seekingalpha.com

Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment

November 12, 2022 | finance.yahoo.com

Cardinal Health (NYSE:CAH) Has Announced A Dividend Of $0.4957

November 10, 2022 | benzinga.com

Cardinal Health Recent Insider Activity

November 10, 2022 | benzinga.com

CEO At This Health Care Company Sells $4.95M of Stock

November 9, 2022 | finance.yahoo.com

Cardinal Health First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags

November 7, 2022 | finance.yahoo.com

Company News for Nov 7, 2022

November 7, 2022 | finance.yahoo.com

Activist investors want what every investor wants, Cardinal CEO Jason Hollar says

November 6, 2022 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardinal Health (CAH) and RegenXBio (RGNX)

November 4, 2022 | finance.yahoo.com

Cardinal Health Extends Breakout As Pharma Biz Outplays Medical Challenges

November 4, 2022 | msn.com

Recap: Cardinal Health Q1 Earnings

November 4, 2022 | markets.businessinsider.com

Cardinal Health Reaffirms FY23 Outlook - Update

November 4, 2022 | nasdaq.com

CAH vs. MCK: These Healthcare Stocks are Hot and Can Stay Hot

November 4, 2022 | markets.businessinsider.com

Cardinal Health Inc Q1 Profit Decreases, but beats estimates

November 4, 2022 | barrons.com

Cardinal Stock Is Soaring. The Earnings Beat Is ‘Very Encouraging.’

November 4, 2022 | seekingalpha.com

Cardinal Health, Inc. (CAH) Q1 2023 Earnings Call Transcript

November 3, 2022 | msn.com

Earnings Preview For Cardinal Health

November 2, 2022 | finance.yahoo.com

Cardinal Health (NYSE:CAH) Hasn't Managed To Accelerate Its Returns

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

CAH Company Calendar

Ex-Dividend for 10/15 Dividend: 9/30/2022
Dividend Payable: 10/15/2022
Last Earnings: 11/04/2022
Today: 12/01/2022
Ex-Dividend for 1/15 Dividend: 12/30/2022
Dividend Payable: 1/15/2023
Next Earnings (Estimated): 2/02/2023
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Drugs, proprietaries, & sundries
Sub-Industry: Health Care Distributors
Sector: Medical
Current Symbol: NYSE:CAH
CUSIP: 14149Y10
CIK: 721371
Web: www.cardinalhealth.com
Phone: (614) 757-5000
Fax: 614-757-6000
Employees: 46,500
Year Founded: 1971

Price Target and Rating

Average Stock Price Forecast: $76.45
High Stock Price Forecast: $82.00
Low Stock Price Forecast: $67.00
Forecasted Upside/Downside: -4.1%
Consensus Rating: Hold
Rating Score (0-4): 2.27
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): $6.12
Trailing P/E Ratio: 13.03
Forward P/E Ratio: 15.10
P/E Growth: 1.33
Net Income: $-933,000,000.00
Net Margins: -0.59%
Pretax Margin: -0.55%
Return on Equity: -252.82%
Return on Assets: 3.18%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.04
Quick Ratio: 0.53

Sales & Book Value

Annual Sales: $181.36 billion
Price / Sales: 0.12
Cash Flow: $7.84 per share
Price / Cash Flow: 10.17
Book Value: ($6.79) per share
Price / Book: -11.74

Miscellaneous

Outstanding Shares: 262,130,000
Free Float: 261,688,000
Market Cap: $20.90 billion
Optionable: Optionable
Beta: 0.80

Social Links

Key Executives

Mr. Jason M. Hollar (Age 49)
CEO & Director
Comp: $1.12M

Ms. Jessica L. Mayer (Age 52)
Chief Legal & Compliance Officer
Comp: $873.45k

Mr. Stephen M. Mason (Age 50)
Chief Exec. Officer of Medical Segment
Comp: $848.88k

Ms. Patricia M. English (Age 42)
Sr. VP & Interim CFO

Ms. Mary C. Scherer
Sr. VP & Chief Accounting Officer

Ms. Michelle Greene
Exec. VP & Chief Information Officer and Global Bus. Services

Mr. Kevin Moran
VP of Investor Relations

Ms. Ola M. Snow (Age 54)
Chief HR Officer

Mr. Craig Cowman
Exec. VP of Strategic Sourcing & Manufacturer Services

Ms. Deborah L. Weitzman
Chief Exec. Officer of Pharmaceutical Distribution

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CAH Stock - Frequently Asked Questions

Should I buy or sell Cardinal Health stock right now?: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.
What is Cardinal Health's stock price forecast for 2023?: 11 brokers have issued 1-year price objectives for Cardinal Health's stock. Their CAH share price forecasts range from $67.00 to $82.00. On average, they expect the company's share price to reach $76.45 in the next twelve months. This suggests that the stock has a possible downside of 4.6%.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.
How have CAH shares performed in 2022?: Cardinal Health's stock was trading at $51.49 at the beginning of 2022. Since then, CAH shares have increased by 55.7% and is now trading at $80.17.
View the best growth stocks for 2022 here.
Are investors shorting Cardinal Health?: Cardinal Health saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 8,550,000 shares, a drop of 28.3% from the October 31st total of 11,920,000 shares. Based on an average daily volume of 3,090,000 shares, the days-to-cover ratio is presently 2.8 days. Currently, 3.3% of the company's shares are short sold.
View Cardinal Health's Short Interest.
When is Cardinal Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our CAH earnings forecast.
How were Cardinal Health's earnings last quarter?: Cardinal Health, Inc. (NYSE:CAH) posted its quarterly earnings results on Friday, November, 4th. The company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.24. The business earned $49.60 billion during the quarter, compared to analysts' expectations of $46.88 billion. Cardinal Health had a negative net margin of 0.59% and a negative trailing twelve-month return on equity of 252.82%.
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?: Cardinal Health announced a quarterly dividend on Tuesday, November 8th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.4957 per share on Sunday, January 15th. This represents a $1.98 annualized dividend and a yield of 2.47%. The ex-dividend date is Friday, December 30th.
Read our dividend analysis for CAH.
Is Cardinal Health a good dividend stock?: Cardinal Health (NYSE:CAH) pays an annual dividend of $1.98 per share and currently has a dividend yield of 2.52%. The company has been increasing its dividend for 36 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 32.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CAH will have a dividend payout ratio of 33.00% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

What guidance has Cardinal Health issued on next quarter's earnings?: Cardinal Health issued an update on its FY 2023 earnings guidance on Friday, November, 18th. The company provided EPS guidance of $5.05-$5.40 for the period, compared to the consensus earnings per share estimate of $5.24. The company issued revenue guidance of -.
What is Mike Kaufmann's approval rating as Cardinal Health's CEO?: 357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.
What other stocks do shareholders of Cardinal Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).
What is Cardinal Health's stock symbol?: Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."
Who are Cardinal Health's major shareholders?: Cardinal Health's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.27%), BlackRock Inc. (10.94%), State Street Corp (7.75%), Price T Rowe Associates Inc. MD (3.13%), Bank of New York Mellon Corp (1.80%) and ProShare Advisors LLC (1.07%). Insiders that own company stock include Michelle Brennan and Ola M Snow.
View institutional ownership trends.
How do I buy shares of Cardinal Health?: Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cardinal Health's stock price today?: One share of CAH stock can currently be purchased for approximately $80.17.
How much money does Cardinal Health make?: Cardinal Health (NYSE:CAH) has a market capitalization of $21.02 billion and generates $181.36 billion in revenue each year. The company earns $-933,000,000.00 in net income (profit) each year or $6.12 on an earnings per share basis.
How many employees does Cardinal Health have?: The company employs 46,500 workers across the globe.
Does Cardinal Health have any subsidiaries?: The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Aero-Med LLC, Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Blue Robin LLC, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 LLC, Cardinal Health 104 LP, Cardinal Health 105 LLC, Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 LLC, Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health K.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies LLC, Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR U.S. LLC, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Mirixa Corporation, Mirixa Corporation, MosaicGPO LLC, NaviHealth, One Cloverleaf LLC, Outcomes Incorporated, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Patient Recovery Business of Medtronic, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises LLC, RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, mscripts, and mscripts LLC.
Read More
How can I contact Cardinal Health?: Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.

This page (NYSE:CAH) was last updated on 12/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial